HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $126
10/12/2026
Impact: 85
Healthcare
HC Wainwright & Co. analyst Matthew Caufield has maintained a 'Buy' rating on Kodiak Sciences (NASDAQ: KOD) and raised the price target from $96 to $126. This adjustment reflects a positive outlook for the company in the market.
AI summary, not financial advice
Share: